The Indian in vitro diagnostic market - an overviewSchenella Menda
Looking for data on the Indian IVD market? Here is an overview of the market, its segments and a brief description of every segment. I hope you enjoy reading it.
The third edition of the EvaluateMedTech® World Preview reveals that the global medtech market is expected to grow at 5% annually between 2013 and 2020, reaching $514 billion in sales by 2020. In vitro diagnostics is projected to remain the largest device area with $71.6 billion in sales in 2020. Johnson & Johnson is currently forecast to be the market leader in 2020, but this could change if Medtronic's acquisition of Covidien is completed, making Medtronic the new leader. The report also finds increasing M&A activity, venture financing, and IPOs in the medtech industry.
The Point of Care Diagnostics Market 2014-2024Visiongain
This document provides an overview and market analysis of the point of care diagnostics market from 2014 to 2024. It discusses key segments of the market such as blood glucose testing, coagulation testing, cardiac marker testing, and infectious disease testing. It also profiles the leading companies in the point of care diagnostics market, including Roche, Abbott, Siemens, and Alere. The document contains sales forecasts for the global point of care diagnostics market and various regional markets from 2014 to 2024. It identifies factors driving growth in the point of care diagnostics field as well as challenges faced by new entrants.
India IVD (Instruments & Reagents) Market, Share, Registration, Regulations &...iGATE RESEARCH
iGATE Research has released a research report on “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
China Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparame...ReportsnReports
This report provides an analysis of the patient monitoring market in China, including market segmentation, revenue forecasts, volume forecasts and average pricing from 2004-2018 for major product categories. It also examines company market shares and distribution channels. The 166-page report contains detailed data tables, profiles of key companies, and was published in September 2012 with a single user license price of $2,500.
IQ4I Research & Consultancy published a New Report on “Lab Automation Global ...Pranesh Sujayeendra
The global Lab automation market is valued at $3.5 billion in 2014. This report analyzes the lab automation market in terms of market revenue ($ million) for all segments. The market analysis is performed by Technique (Total Laboratory Automation & Modular Automation), Process (Hardware & Software), Applications (Clinical Diagnostic Laboratories, Drug Discovery & Development, Bioresearch, Forensic & Others), End-user (Academic & Research Institutes, Biotech/Pharma companies, Hospitals/Laboratory Diagnostics and Others) and Regional markets (North America, Europe, Asia-Pacific and Rest of the World).
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
The Indian in vitro diagnostic market - an overviewSchenella Menda
Looking for data on the Indian IVD market? Here is an overview of the market, its segments and a brief description of every segment. I hope you enjoy reading it.
The third edition of the EvaluateMedTech® World Preview reveals that the global medtech market is expected to grow at 5% annually between 2013 and 2020, reaching $514 billion in sales by 2020. In vitro diagnostics is projected to remain the largest device area with $71.6 billion in sales in 2020. Johnson & Johnson is currently forecast to be the market leader in 2020, but this could change if Medtronic's acquisition of Covidien is completed, making Medtronic the new leader. The report also finds increasing M&A activity, venture financing, and IPOs in the medtech industry.
The Point of Care Diagnostics Market 2014-2024Visiongain
This document provides an overview and market analysis of the point of care diagnostics market from 2014 to 2024. It discusses key segments of the market such as blood glucose testing, coagulation testing, cardiac marker testing, and infectious disease testing. It also profiles the leading companies in the point of care diagnostics market, including Roche, Abbott, Siemens, and Alere. The document contains sales forecasts for the global point of care diagnostics market and various regional markets from 2014 to 2024. It identifies factors driving growth in the point of care diagnostics field as well as challenges faced by new entrants.
India IVD (Instruments & Reagents) Market, Share, Registration, Regulations &...iGATE RESEARCH
iGATE Research has released a research report on “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
China Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparame...ReportsnReports
This report provides an analysis of the patient monitoring market in China, including market segmentation, revenue forecasts, volume forecasts and average pricing from 2004-2018 for major product categories. It also examines company market shares and distribution channels. The 166-page report contains detailed data tables, profiles of key companies, and was published in September 2012 with a single user license price of $2,500.
IQ4I Research & Consultancy published a New Report on “Lab Automation Global ...Pranesh Sujayeendra
The global Lab automation market is valued at $3.5 billion in 2014. This report analyzes the lab automation market in terms of market revenue ($ million) for all segments. The market analysis is performed by Technique (Total Laboratory Automation & Modular Automation), Process (Hardware & Software), Applications (Clinical Diagnostic Laboratories, Drug Discovery & Development, Bioresearch, Forensic & Others), End-user (Academic & Research Institutes, Biotech/Pharma companies, Hospitals/Laboratory Diagnostics and Others) and Regional markets (North America, Europe, Asia-Pacific and Rest of the World).
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
Colocation Market 5 Year Meticulous Analysis and Competitive Landscape ReportPete Jones
Colocation Market report provides a 5 year comprehensive analysis along with competitive landscape, manufacturing processes, cost structures and more in a new report.
The document summarizes opportunities in the Indian diagnostic industry in 2018. It finds that the industry grew significantly from 2009-2013 and is projected to continue strong growth to 2018. The in-vitro diagnostics segment grew revenues from $463.5 million to an estimated $1.25 billion from 2012-2018, driven by growth in areas like hematology and molecular diagnostics. The imaging diagnostics segment grew revenues from $645.1 million to a projected $1 billion from 2012-2018, aided by increased investments in advanced technologies and awareness. Overall, the diagnostic and pathology services market in India generated $2.2 billion in revenues in 2012 and is estimated to reach $4.37 billion by 2018.
Saudi Arabia Facility Management Market (2021-2026) - MarkNtel AdvisorsMarkNtel Advisors
According to MarkNtel Advisors’ research report “Saudi Arabia Facility Management Market Analysis, 2021”, the Saudi Arabia Facility Management market is anticipated to grow at a CAGR of around 15% during 2021-26F.
Full Report - https://www.marknteladvisors.com/research-library/saudi-arabia-facility-management-market.html
Indian coronary stent market forecast to 2019IBNARESEARCH
This document provides a summary and table of contents for a market research report on the Indian coronary stent market forecast to 2019. The report contains 10 chapters analyzing topics such as the demographic and economic landscape in India, regulations for medical devices, taxation, the industry and production, import/export trends, consumers, pricing, the current market size and outlook. It aims to provide decision-makers in the coronary stent manufacturing industry with insights into market dynamics and growth opportunities in India.
Markntel Asia-Pacific Digital Respiratory Medical Devices Market Analysis, 2020ShivaKumar1833
COVID-19 pandemic has been emerging as a game-changer for digital respiratory devices. The sudden spike in demand is expected to achieve normalcy by 2023, however, as a precautionary measure, the countries in the region are expected to focus on capacity building in healthcare infrastructure. For more detail visit us at marknteladvisors.com or call us at +1 (613) 707-5086
China has become an important supplier of pharmaceutical ingredients to both generic and innovative drug companies. While China was once mainly a source of low-cost ingredients, it is now moving into developing processes for newer drug molecules and supplying higher quality ingredients. The number of Chinese manufacturers capable of supplying regulated international markets has greatly increased in recent years. However, most Chinese manufacturers are still focused on the domestic market and issues around regulatory compliance, intellectual property protection, and cultural differences still present challenges to doing business in China.
Market Research Report :Coronary stents market in india 2013Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.
Table of Contents:
This document summarizes ten fast growing technologies from 2014-2019 based on increases in US pre-grant patent classifications. It provides an overview of the methodology used to identify these technologies and then summarizes each one in 1-2 paragraphs, including the classification, growth rate, leading organizations, and examples of relevant patents. The ten technologies summarized are: 1) Angiosperms characterized by botanic taxonomy, 2) Genome editing, 3) Medicinal preparations, 4) Arrangements or adaptations of instruments/dashboards, 5) Physical training - horizontal bars, 6) Computer systems based on computational models, 7) Additive manufacturing, 8) Aeroplanes and helicopters, 9) Systems for controlling non-electric variables, and 10
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
The document summarizes the results of a 2008 survey of 212 IT decision makers from various industries on trends in the colocation industry. Key findings include: improved reliability and performance at lower cost were top factors for colocating; over 2/3 of respondents expected ROI on their colocation investment within 2 years; and managed services like remote hands were seen as the most valuable offerings from colocation providers. Security, redundancy and bandwidth were top considerations in choosing providers.
The document provides an overview of the diagnostics market in Asia from 2009-2010. It finds that the market is expected to grow at a CAGR of 8.5% due to factors like an aging population, increasing healthcare spending, and a shift toward preventative care. The largest national markets are China, expected to grow at 14.5% CAGR, and India at 12.1% CAGR. Leading segments are immunoassay, clinical chemistry and self-monitoring of blood glucose. Emerging areas of growth include molecular diagnostics, point-of-care testing and laboratory automation.
Markntel Global Pharmaceutical Packaging Market Analysis, 2020ShivaKumar1833
The outbreak of COVID-19 is also positively impacting the growth of the global market. The increasing number of coronavirus across the globe is generating more demand for medicines, eventually boosting the global pharmaceutical packaging market. For more detail visit us at marknteladvisors.com or call us at +1 (613) 707-5086
United Arab Emirates Patient Monitoring Investment Opportunities, Analysis an...ReportsnReports
The document is a 158-page report from Global Markets Direct analyzing the patient monitoring market in the United Arab Emirates from 2004-2018. It provides historical data on market size, volume and pricing for various segments, as well as forecasts to 2018. It also includes company share and distribution share data for key players in each segment of the UAE patient monitoring market. The report is available for purchase for $2,500.
Global 5G Substrate Market Analysis, Share, Forecast 2025MarkNtel Advisors
The document is a market analysis report on global 5G substrate materials from 2015 to 2025. It includes segmentation by type, application, region, and key companies. The COVID-19 pandemic initially slowed market growth due to supply chain disruptions and factory closures. However, increasing smartphone penetration driving demand for materials used in antennas is expected to increase market revenues and volumes at compound annual growth rates provided. The report also analyzes the market share of materials like ceramics, glass, and organic laminates with forecasts through 2025.
Global Blood Screening Market Analysis, 2020 -MarkNtel AdvisorsMarkNtel Advisors
According to MarkNtel Advisors’ research report titled “Global Blood Screening Market Analysis, 2020”, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F .
Full Report - https://www.marknteladvisors.com/research-library/global-blood-screening-market.html
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
IFI CLAIMS examined US patent filings from 2013–2017 to determine the fastest growing technologies and the companies with the most applications in each classification.
Lifesciences IT - 2011 YearbookSummaryGBI Research's research, 'Lifesciences IT - 2011 Yearbook" provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical companies. GBI Research expects that information technology (IT) in the lifesciences industry will become a trendsetter, helping pharmaceutical companies mitigate current and evolving industry challenges. IT solutions utilized in the value chain of pharmaceutical companies help them to operate effectively and efficiently. GBI expects an increase in the adoption of IT by pharmaceutical companies looking to remain competitive in the market place. The Lifesciences industry is pressurized by various challenges such as declining Return on Investment (ROI) on R&D investments, entry of generics and layoffs. These factors are responsible for the lifesciences companies to invest in information technology solutions. Pharmaceutical companies have found that experimental techniques are costly, time-consuming, and involve the use of large numbers of animals for testing and are adapting to computerized combinatorial chemistry applications. Pharmaceutical Companies are increasingly adopting e-clinical trial solutions in the drug development phase. Cutting down clinical trial cost is the driving motivation for the adoption of e-clinical trial solutions. Services offered by IT companies in clinical data management are costly but have been proved to save cost for the companies in the long run. CTMS and EDC will attract the highest investments in the future followed by data mining, electronic submission tools and RFID. Outsourcing helps a pharmaceutical company to reduce costs by 30-35% and this is one of the main reasons why pharmaceutical companies outsource non-core R&D operational work to IT companies. When selecting a country to outsource clinical data management work, building the required competencies to tackle client requirements has gained a higher importance than the cost advantage it provides. The predictive analytics helps a company view beyond the sales volume in to real time prescribing patterns, as a behavior of continuum. This also helps the company to follow the evolving niche buster model. Many pharmaceutical companies have increased satisfaction levels from their customers in 2008. In 2004, 50% of the physicians were satisfied on the current number of calls. However, satisfaction levels have increased in 2008 with more than 57% of the physicians in the US satisfied with the current number of calls. The increase in satisfaction levels was directly proportional to the decrease of sales force in the US. It is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes - - Analysis of the leading segments in the Lifesciences IT market - Key drivers and barriers that have a significant impact on the Lifesciences IT market. - Competitive benchmarking of leading companies in the market. - Key M&A activities and strategic partnership deals that have taken place in 2009.- Inputs for customized IT solution based on business situation.Reasons to buyThe report will enhance your decision making capability. It will provide you with - - Align your product portfolio to the markets with high growth potential.- Develop market-entry and market expansion strategies by identifying the leading segments poised for strong growth.- Device better strategies through the understanding of key drivers and barriers in the market.- Develop key strategic initiatives by understanding the key focus of leading companies.- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Real-Time Locating System (RTLS) Market – Global Forecast to 2024infoholicresearch-llp
The document provides an overview and market analysis of the global real-time locating systems (RTLS) market. It discusses key growth drivers such as the increasing focus on optimizing operational performance across industries. The report also examines market trends, including the growing adoption of analytics and cloud-based IoT solutions. Additionally, it analyzes the RTLS market by technology, components, industry verticals, and regions from 2018-2024.
Colocation Market 5 Year Meticulous Analysis and Competitive Landscape ReportPete Jones
Colocation Market report provides a 5 year comprehensive analysis along with competitive landscape, manufacturing processes, cost structures and more in a new report.
The document summarizes opportunities in the Indian diagnostic industry in 2018. It finds that the industry grew significantly from 2009-2013 and is projected to continue strong growth to 2018. The in-vitro diagnostics segment grew revenues from $463.5 million to an estimated $1.25 billion from 2012-2018, driven by growth in areas like hematology and molecular diagnostics. The imaging diagnostics segment grew revenues from $645.1 million to a projected $1 billion from 2012-2018, aided by increased investments in advanced technologies and awareness. Overall, the diagnostic and pathology services market in India generated $2.2 billion in revenues in 2012 and is estimated to reach $4.37 billion by 2018.
Saudi Arabia Facility Management Market (2021-2026) - MarkNtel AdvisorsMarkNtel Advisors
According to MarkNtel Advisors’ research report “Saudi Arabia Facility Management Market Analysis, 2021”, the Saudi Arabia Facility Management market is anticipated to grow at a CAGR of around 15% during 2021-26F.
Full Report - https://www.marknteladvisors.com/research-library/saudi-arabia-facility-management-market.html
Indian coronary stent market forecast to 2019IBNARESEARCH
This document provides a summary and table of contents for a market research report on the Indian coronary stent market forecast to 2019. The report contains 10 chapters analyzing topics such as the demographic and economic landscape in India, regulations for medical devices, taxation, the industry and production, import/export trends, consumers, pricing, the current market size and outlook. It aims to provide decision-makers in the coronary stent manufacturing industry with insights into market dynamics and growth opportunities in India.
Markntel Asia-Pacific Digital Respiratory Medical Devices Market Analysis, 2020ShivaKumar1833
COVID-19 pandemic has been emerging as a game-changer for digital respiratory devices. The sudden spike in demand is expected to achieve normalcy by 2023, however, as a precautionary measure, the countries in the region are expected to focus on capacity building in healthcare infrastructure. For more detail visit us at marknteladvisors.com or call us at +1 (613) 707-5086
China has become an important supplier of pharmaceutical ingredients to both generic and innovative drug companies. While China was once mainly a source of low-cost ingredients, it is now moving into developing processes for newer drug molecules and supplying higher quality ingredients. The number of Chinese manufacturers capable of supplying regulated international markets has greatly increased in recent years. However, most Chinese manufacturers are still focused on the domestic market and issues around regulatory compliance, intellectual property protection, and cultural differences still present challenges to doing business in China.
Market Research Report :Coronary stents market in india 2013Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.
Table of Contents:
This document summarizes ten fast growing technologies from 2014-2019 based on increases in US pre-grant patent classifications. It provides an overview of the methodology used to identify these technologies and then summarizes each one in 1-2 paragraphs, including the classification, growth rate, leading organizations, and examples of relevant patents. The ten technologies summarized are: 1) Angiosperms characterized by botanic taxonomy, 2) Genome editing, 3) Medicinal preparations, 4) Arrangements or adaptations of instruments/dashboards, 5) Physical training - horizontal bars, 6) Computer systems based on computational models, 7) Additive manufacturing, 8) Aeroplanes and helicopters, 9) Systems for controlling non-electric variables, and 10
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
The document summarizes the results of a 2008 survey of 212 IT decision makers from various industries on trends in the colocation industry. Key findings include: improved reliability and performance at lower cost were top factors for colocating; over 2/3 of respondents expected ROI on their colocation investment within 2 years; and managed services like remote hands were seen as the most valuable offerings from colocation providers. Security, redundancy and bandwidth were top considerations in choosing providers.
The document provides an overview of the diagnostics market in Asia from 2009-2010. It finds that the market is expected to grow at a CAGR of 8.5% due to factors like an aging population, increasing healthcare spending, and a shift toward preventative care. The largest national markets are China, expected to grow at 14.5% CAGR, and India at 12.1% CAGR. Leading segments are immunoassay, clinical chemistry and self-monitoring of blood glucose. Emerging areas of growth include molecular diagnostics, point-of-care testing and laboratory automation.
Markntel Global Pharmaceutical Packaging Market Analysis, 2020ShivaKumar1833
The outbreak of COVID-19 is also positively impacting the growth of the global market. The increasing number of coronavirus across the globe is generating more demand for medicines, eventually boosting the global pharmaceutical packaging market. For more detail visit us at marknteladvisors.com or call us at +1 (613) 707-5086
United Arab Emirates Patient Monitoring Investment Opportunities, Analysis an...ReportsnReports
The document is a 158-page report from Global Markets Direct analyzing the patient monitoring market in the United Arab Emirates from 2004-2018. It provides historical data on market size, volume and pricing for various segments, as well as forecasts to 2018. It also includes company share and distribution share data for key players in each segment of the UAE patient monitoring market. The report is available for purchase for $2,500.
Global 5G Substrate Market Analysis, Share, Forecast 2025MarkNtel Advisors
The document is a market analysis report on global 5G substrate materials from 2015 to 2025. It includes segmentation by type, application, region, and key companies. The COVID-19 pandemic initially slowed market growth due to supply chain disruptions and factory closures. However, increasing smartphone penetration driving demand for materials used in antennas is expected to increase market revenues and volumes at compound annual growth rates provided. The report also analyzes the market share of materials like ceramics, glass, and organic laminates with forecasts through 2025.
Global Blood Screening Market Analysis, 2020 -MarkNtel AdvisorsMarkNtel Advisors
According to MarkNtel Advisors’ research report titled “Global Blood Screening Market Analysis, 2020”, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F .
Full Report - https://www.marknteladvisors.com/research-library/global-blood-screening-market.html
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
IFI CLAIMS examined US patent filings from 2013–2017 to determine the fastest growing technologies and the companies with the most applications in each classification.
Lifesciences IT - 2011 YearbookSummaryGBI Research's research, 'Lifesciences IT - 2011 Yearbook" provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical companies. GBI Research expects that information technology (IT) in the lifesciences industry will become a trendsetter, helping pharmaceutical companies mitigate current and evolving industry challenges. IT solutions utilized in the value chain of pharmaceutical companies help them to operate effectively and efficiently. GBI expects an increase in the adoption of IT by pharmaceutical companies looking to remain competitive in the market place. The Lifesciences industry is pressurized by various challenges such as declining Return on Investment (ROI) on R&D investments, entry of generics and layoffs. These factors are responsible for the lifesciences companies to invest in information technology solutions. Pharmaceutical companies have found that experimental techniques are costly, time-consuming, and involve the use of large numbers of animals for testing and are adapting to computerized combinatorial chemistry applications. Pharmaceutical Companies are increasingly adopting e-clinical trial solutions in the drug development phase. Cutting down clinical trial cost is the driving motivation for the adoption of e-clinical trial solutions. Services offered by IT companies in clinical data management are costly but have been proved to save cost for the companies in the long run. CTMS and EDC will attract the highest investments in the future followed by data mining, electronic submission tools and RFID. Outsourcing helps a pharmaceutical company to reduce costs by 30-35% and this is one of the main reasons why pharmaceutical companies outsource non-core R&D operational work to IT companies. When selecting a country to outsource clinical data management work, building the required competencies to tackle client requirements has gained a higher importance than the cost advantage it provides. The predictive analytics helps a company view beyond the sales volume in to real time prescribing patterns, as a behavior of continuum. This also helps the company to follow the evolving niche buster model. Many pharmaceutical companies have increased satisfaction levels from their customers in 2008. In 2004, 50% of the physicians were satisfied on the current number of calls. However, satisfaction levels have increased in 2008 with more than 57% of the physicians in the US satisfied with the current number of calls. The increase in satisfaction levels was directly proportional to the decrease of sales force in the US. It is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes - - Analysis of the leading segments in the Lifesciences IT market - Key drivers and barriers that have a significant impact on the Lifesciences IT market. - Competitive benchmarking of leading companies in the market. - Key M&A activities and strategic partnership deals that have taken place in 2009.- Inputs for customized IT solution based on business situation.Reasons to buyThe report will enhance your decision making capability. It will provide you with - - Align your product portfolio to the markets with high growth potential.- Develop market-entry and market expansion strategies by identifying the leading segments poised for strong growth.- Device better strategies through the understanding of key drivers and barriers in the market.- Develop key strategic initiatives by understanding the key focus of leading companies.- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Real-Time Locating System (RTLS) Market – Global Forecast to 2024infoholicresearch-llp
The document provides an overview and market analysis of the global real-time locating systems (RTLS) market. It discusses key growth drivers such as the increasing focus on optimizing operational performance across industries. The report also examines market trends, including the growing adoption of analytics and cloud-based IoT solutions. Additionally, it analyzes the RTLS market by technology, components, industry verticals, and regions from 2018-2024.
Asia Pacific Bioinformatics Market Research Report: Forecast (2021-2026) - Ma...MarkNtel Advisors
Bioinformatics is a sub-discipline of biology and computer science that involves both hardware and software to obtain, store, and interpret large quantities of biological data.
Read More - https://www.marknteladvisors.com/research-library/asia-pacific-bioinformatics-market.html
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...IMARC Group
The Japan laboratory informatics market size is projected to exhibit a growth rate (CAGR) of 5.30% during 2024-2032.
More Info:- https://www.imarcgroup.com/japan-laboratory-informatics-market
- Product Engineering Services growth slowed compared to overall IT services growth, with European service providers growing faster than large Indian heritage providers.
- Overall R&D spending among top companies increased slightly, with automotive and healthcare expected to increase spending while telecom and energy may decrease spending. Industry consolidation continued through M&As.
- Over 50 new R&D centers were announced to be set up globally, mostly in Asia focused on ISV/computer peripherals. India remained the most preferred location for R&D globalization.
South East Asia Building Automation Market Analysis, 2020AdrenaSharma
According to MarkNtel Advisors’ research report titled “South East Asia Building Automation System Market Analysis, 2020”, the South East Asia Building Automation market is anticipated to grow at a CAGR of around 13% during 2020-25.
Project Report on TFT LCD Manufacturing PlantIMARC Group
The report provides a complete roadmap for setting up an tft lcd manufacturing plant. It covers a comprehensive market overview to micro-level information such as unit operations involved, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.
More Info:- https://www.imarcgroup.com/tft-lcd-manufacturing-plant-project-report
#Manufacturing #PlantSetup #IMARCGroup #PlantReport
Network Functions Virtualization (NFV) Market - Global Outlook (2017-21)ResearchFox
According to the experts in the field of NFV, the whole idea behind the emergence of this technology was to provide simplified telecommunication functions to user, which are otherwise complex and tough to manage. Introduction of NFV is providing the necessary scaling of telecom infrastructure and also allowing the reduction of CAPEX and OPEX costs. Above all, the major driving force behind the growth of the technology is the great flexibility and speed that this solution is expected to provide. The market for Network Functions Virtualizations is slowly catching up and this report provides deep insights on how the market is expected to fare in the next five years. It also presents interpretative and easyto-understand facts on how the current market is segmented based on the geography, the end-user and the type of customers using it.
The global Smart Factory market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Smart Factory market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Markntel Global Female Technology (FemTech) Market Analysis, 2020ShivaKumar1833
The outbreak of COVID-19 generated the situation of lockdowns and increasing the number of patients’ footfall in the hospitals and diagnostic centers. This resulted into deferred non-essential diagnostic testing and general health treatment of females, therefore, the women are preferring to utilize female technology for consultation, nursing care, pregnancy care, etc. globally.
Global Digital Surgery Technologies Market 2021-2026 - MarkNtel AdvisorsMarkNtel Advisors
According to the MarkNtel Advisors research report Global Digital Surgery Technologies Market Analysis 2021 the market is likely to grow at a CAGR of around 22% during (2021-26).
Reports URL - https://www.marknteladvisors.com/research-library/global-digital-surgery-technologies-market.html
According to the MarkNtel Advisors’ research report, “UAE Telehealth Market Analysis, 2021,” the market is likely to grow at a CAGR of around 25% during 2021-26 due to the surging consumer demand & patient acceptance for enhanced quality of care, the burgeoning geriatric population, and the increasing number of chronic diseases, such as cancer, diabetes, and neurological issues.
Video Surveillance Market in India - A Blueprint to Enhance SalesNeil Dave
The Video Surveillance Market in India is expected to reach USD 4.8 Billion by the year 2025, growing at a CAGR of 16.2% during the forecast period of 2020-2025.
The focus of this presentation is to keep Industry Participants abreast of major infrastructure developments across 8 key end-user sectors that are expected to result in high-value sales opportunities in the near term future.
This presentation also sheds light on the key trends within the Video Surveillance Market in India in terms of market size and growth forecasts, market segmentation, market drivers and restraints.
The document provides an overview and market analysis of the global Internet of Things market from 2015 to 2021. It covers the IoT architecture and value chain, market segmentation by application and enabling technology, as well as drivers, restraints, opportunities and challenges. Key findings include that the global IoT market is expected to grow at a CAGR of 16.05% during 2015-2021, with cloud management services dominating. Commercial applications like mobility and energy are forecasted to be the fastest growing segments.
This document describes the Medical Device Gateway (MDG) program, a Chinese-Finnish network aimed at commercializing medical device technologies. The program seeks to bring Chinese medical device innovations to European markets through Finnish companies, and to open Chinese markets to Finnish medical ventures. It identifies opportunities in the large and growing Chinese IVD market and regulatory changes making it more accessible. The document outlines the program's operations of establishing strategic partnerships between Finnish and Chinese organizations to more quickly develop and place new products on global markets.
Collaborative Robot Market by Product Type, Distribution Channel, End User 20...IMARC Group
The global collaborative robot market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.8 Billion by 2032, exhibiting a growth rate (CAGR) of 37.98% during 2024-2032.
More Info:- https://www.imarcgroup.com/collaborative-robot-market
1 industry 4.0 insights by khalid sulami.pdf (1)-compressedKhalid AlSulami
The document discusses Saudi Arabia's national strategy for Industry 4.0. It aims to accelerate investments in the technologies of the Fourth Industrial Revolution to increase competitiveness. The key points are:
1. The strategy will focus on increasing competitive advantage in existing industries and developing an enabling system for Industry 4.0 technologies.
2. It seeks to increase competitiveness, expand value chains, mitigate impacts of reforms, develop technical suppliers locally and create high-skill jobs.
3. Foundational elements include raising awareness through promotions and exhibitions, developing competencies through education and training programs.
industry 4.0 Saudi Arabia insights by khalid sulami.pdfKhalid AlSulami
The document discusses Saudi Arabia's national strategy for Industry 4.0. It aims to accelerate investments in the technologies of the Fourth Industrial Revolution to increase competitiveness. The key points are:
1) The strategy will focus on increasing competitive advantage in existing industries and developing an environment supportive of Industry 4.0 technologies.
2) It seeks to do this through financing programs, developing skills, and supporting technology adoption among companies.
3) The vision is for Industry 4.0 to boost existing industries and jobs in Saudi Arabia through technologies like advanced manufacturing, robotics, and data analytics.
Similar to China Laboratory Informatics Market Research Report: Forecast (2021-2026) (20)
Global Sustainable Aviation Fuel Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Sustainable Aviation Fuel Market size was valued at USD 610 billion in 2022 and is projected to grow at a CAGR of around 56.32% during the forecast period, i.e., 2023-28.
Global Sustainable Aviation Fuel Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Sustainable Aviation Fuel Market size was valued at USD 610 billion in 2022 and is projected to grow at a CAGR of around 56.32% during the forecast period, i.e., 2023-28.
Global Food Inclusions Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Food Inclusions Market size was valued at around USD 13 billion in 2022 & is projected to grow at a CAGR of about 25% during the forecast period, i.e., 2023-28.
Global Food Inclusions Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Food Inclusions Market size was valued at around USD 13 billion in 2022 & is projected to grow at a CAGR of about 25% during the forecast period, i.e., 2023-28.
Global Food Inclusions Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Food Inclusions Market size was valued at around USD 13 billion in 2022 & is projected to grow at a CAGR of about 25% during the forecast period, i.e., 2023-28.
Global Lateral Flow Assay Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Lateral Flow Assay Market was valued at USD9.3 billion in 2022 and is projected to grow at a CAGR of around 3.4% during the forecast period, i.e., 2023-28.
Global Lateral Flow Assay Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Lateral Flow Assay Market was valued at USD9.3 billion in 2022 and is projected to grow at a CAGR of around 3.4% during the forecast period, i.e., 2023-28.
Global Lateral Flow Assay Market Research Report: Forecast (2023-2028)sonukumar765969
The Global Lateral Flow Assay Market was valued at USD9.3 billion in 2022 and is projected to grow at a CAGR of around 3.4% during the forecast period, i.e., 2023-28.
According to the MarkNtel Advisors’ research report, “Kuwait Facility Management Market Analysis, 2020”, the facility management market is projected to register a CAGR of around 8% during 2020-25.
According to the MarkNtel Advisors’ research report, “Kuwait Facility Management Market Analysis, 2020”, the facility management market is projected to register a CAGR of around 8% during 2020-25.
About CentiUP - Product Information Slide.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
English Drug and Alcohol Commissioners June 2024.pptxMatSouthwell1
Presentation made by Mat Southwell to the Harm Reduction Working Group of the English Drug and Alcohol Commissioners. Discuss stimulants, OAMT, NSP coverage and community-led approach to DCRs. Focussing on active drug user perspectives and interests
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...Dr. David Greene Arizona
Dr. David Greene of Arizona is at the forefront of stem cell therapy for Parkinson's Disease, focusing on innovative treatments to restore dopamine-producing neurons. His research explores the use of embryonic stem cells, induced pluripotent stem cells, and adult stem cells to replace lost neurons and potentially reverse disease progression. By transplanting differentiated cells into affected brain areas, Dr. Greene aims to address the root cause of Parkinson's. His work also investigates the neuroprotective benefits of stem cells, offering hope for effective, long-term treatments. Discover how Dr. Greene's pioneering efforts could transform Parkinson's Disease therapy.
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...DrDevTaneja1
Digital India will need a big trained army of Health Informatics educated & trained manpower in India.
Presently, generalist IT manpower does most of the work in the healthcare industry in India. Academic Health Informatics education is not readily available at school & health university level or IT education institutions in India.
We look into the evolution of health informatics and its applications in the healthcare industry.
HIMMS TIGER resources are available to assist Health Informatics education.
Indian Health universities, IT Education institutions, and the healthcare industry must proactively collaborate to start health informatics courses on a big scale. An advocacy push from various stakeholders is also needed for this goal.
Health informatics has huge employment potential and provides a big business opportunity for the healthcare industry. A big pool of trained health informatics manpower can lead to product & service innovations on a global scale in India.
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
2. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 2
Table of Content (1/4)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
1. Introduction
1.1. Research Process 8
1.2. Product Definition 11
1.3. Acronyms 12
1.4. Market Segmentation 13
2. Executive Summary 14
3. Experts Verbatim- What our Experts Say? 16
4. China Laboratory Informatics Market Analysis, 2015-2025F 19
4.1. Market Size & Analysis
4.1.1. By Revenues 20
4.2. Market Share & Analysis
4.2.1. By Product 22
4.2.1.1. Electronic Lab Notebooks (ELN)
4.2.1.2. Laboratory Information Management Systems (LIMS)
4.2.1.3. Chromatography Data Systems (CDS)
4.2.1.4. Electronic Data Capture (EDC) & Clinical Data Management Systems
4.2.1.5. Laboratory Execution Systems (LES)
4.2.1.6. Enterprise Content Management Systems (ECM)
4.2.1.7. Scientific Data Management Systems
4.2.2. By Components 24
3. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 3
Table of Content (2/4)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
4.2.2.1. Services
4.2.2.2. Software
4.2.3. By Industry 26
4.2.3.1. Pharma & Biotechnology
4.2.3.2. Biobanks & Bio Repositories
4.2.3.3. Molecular Diagnostics & Clinical Research Labs
4.2.3.4. Contract Service Organizations
4.2.3.5. Academia
4.2.4. By Deployment Model 25
4.2.4.1. Remote Hosting
4.2.4.2. On-Premise Models
4.2.4.3. Cloud- Based Models
4.2.5. By Company
4.2.5.1. Revenue Shares 32
4.2.5.2. Strategic Factorial Indexing 33
4.2.5.3. Competitor Placement in MarkNtel Quadrant 34
5. China Laboratory Informatics Market Policies, Regulations, Product Standards 36
6. China Laboratory Informatics Market Trends & Insights 38
7. China Laboratory Informatics Market Dynamics 41
7.1. Growth Drivers 43
4. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 4
Table of Content (3/4)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
7.2. Challenges 44
7.3. Impact Analysis 42
8. China Laboratory Informatics Market Hotspot & Opportunities 45
9. China Laboratory Informatics Market Key Strategic Imperatives for Success & Growth 48
10. China Competition Outlook 50
10.1. Competition Matrix
10.1.1. Product Portfolio
10.1.2. Brand Specialization
10.1.3. Target Markets
10.1.4. Target Industry’s
10.1.5. Research & Development
10.1.6. Strategic Alliances
10.1.7. Strategic Initiatives
10.2. Company Profiles 54
10.2.1. Beijing- Agilent Technologies 55
10.2.2. Beijing LabWare Sci & Tech Co., Ltd. 56
10.2.3. ThermoFisher Scientific 57
10.2.4. LabVantage 58
10.2.5. LabLynx 59
10.2.6. Autoscribe 60
5. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 5
Table of Content (4/4)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
10.2.7. Abbott Informatics 61
10.2.8. Perkin Elmer 62
10. Disclaimer 63
6. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 6
Acronyms
Acronyms Full Form
ELN Electronic Lab Notebooks
LIMS Laboratory Information Management Systems
CDS Chromatography Data Systems
EDC & CDMS Electronic Data Capture (EDC) & Clinical Data Management Systems
LES Laboratory Execution Systems
ECMS Enterprise Content Management Systems
SDMS Scientific Data Management Systems
The UK The United Kingdom
7. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 7
Market Segmentation
• Electronic Lab Notebooks
(ELN)
• Laboratory Information
Management Systems (LIMS)
• Chromatography Data Systems
(CDS)
• Electronic Data Capture (EDC)
& Clinical Data Management
Systems
• Laboratory Execution Systems
(LES)
• Enterprise Content
Management Systems (ECM)
• Scientific Data Management
Systems
China Laboratory Informatics Market Segmentation
By Product By Company
• Services
• Software
By Components
• Pharma & Biotechnology
• Biobanks & Bio
Repositories
• Molecular Diagnostics &
Clinical Research Labs
• Contract Service
Organizations
• Academia
By Application By Deployment
• On-Premise Models
• Cloud- Based
Models
• Agilent
Technologies
• LabWare
• ThermoFisher
Scientific
• LabVantage
• LabLynx
• Autoscribe
• Abbott Informatics
• Perkin Elmer
9. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 9
Executive Summary
55.44 XX XX
XX
2015 2019 2020E 2025F
China Lab Informatics Market Size
(USD Million)
• The Chinese laboratory informatics market was in its embryonic
stage in 2019
• Rising Investments in Creation of Healthcare Infrastructure such as
Specialized Hospitals & care Centers, Expansion of Chemicals
industry, etc. to boost the local lab informatics market
XX%
LIMS Dominated the Market in 2019
(Market Share)
• Around 90% of the utilization of LIMS was limited to the pharma and
biotech sector of the country.
• The penetration of LIMS in other industry verticals is expected to
remain dormant due to budget constraints, perceived complexity in
installation and integration with the existing architecture
LIMS
XX%
8 Competitors Had Half of the Market Share,
8
Players
• ThermoFisher, Perkin Elmer, Waters, LabWare, LabVantage, Autoscribe,
Abbott, Agilent, dominated the Chinese lab informatics market
• Companies operates through a local channel partner to expand their
presence in China
10. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.
China Laboratory Informatics Market
Outlook, 2015-2025F
4
11. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 11
China Laboratory Informatics Market Outlook, By Revenues
Figure 1: China Laboratory Informatics Market Revenues (USD Million) & Unit Sold (Thousands), 2015- 2025F
• The Chinese laboratory informatics market was in its embryonic stage in 2019. The market is majorly driven by the healthcare and life
sciences institutions, while the penetration in other industries such as chemicals, petrochemicals, food and beverages, environmental
testing, etc. remains infinitesimal with minute scope for adoption in the near future as well. It has been found that the adoption of
laboratory informatics is restricted to premier healthcare & life sciences institutions in China. Moreover, an IT integration in specialty care
centers has been rising due to the rise in private investments, focusing on improving operational efficiency by accessing real-time data
inputs.
• During 2017-19, the country’s healthcare institutions received investments of around USDXX bn. A considerable amount was allocated
towards establishing informatics, data analysis, AI and other disruptive solutions. The government has also been emerging as a key
stakeholder in the healthcare market as the limitation on the opening of general clinics, third-party medical institutions are removed.
These developments are set to boost the adoption of laboratory informatics market in the forthcoming years in China.
55.44 XX XX XX XX XX XX XX
XX
XX
XX
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR: XX%
CAGR: XX%
Source: MarkNtel Advisors
12. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 12
China Laboratory Informatics Market Revenue Share, By Revenues
XX XX
XX
XX
XX
2015 2016 2017 2018 2019
Figure 2: China Total Healthcare Institutions, 2015-2019
27,587 XX XX XX XX
6,023 XX XX XX XX
31,927
XX
XX
XX
XX
2015 2016 2017 2018 2019
Total Hospitals Specialized Hospitals Specialized Public Health Institutions
Figure 3: China Specialized Healthcare Institutions, By Type, 2015-2019
Source: National Bureau of Statistics, China
Source: National Bureau of Statistics, China
*Healthcare institutes includes all the hospitals, clinics, specialized treatment centers, test labs, providing medical services to individuals in China
13. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 13
China Laboratory Informatics Market Revenue Share, By Product Types
Figure 4: China Laboratory Informatics Market Revenue Share, By Product Types, 2019 & 2025F
Source: MarkNtel Advisors
• Laboratory Information Management Systems (LIMS): The Chinese laboratory informatics market was majorly dominated by the
laboratory information management systems in 2019. Around XX% of the utilization of LIMS was limited to the pharma and biotech sector
of the country. The penetration of LIMS in other industry verticals is expected to remain dormant due to budget constraints, perceived
complexity in installation and integration with the existing architecture.
• The customer expectations from LIMS providers in China include extremely high user-friendly and easy configurability, flexibility to meet
the tailored requirements, multi-laboratory and location management, unlimited number of screen creation, quick dashboard creation,
etc. While the storage of research data for compliance and validating purpose remains the prime purpose of adoption of LIMS.
• The country possess the massive potential for LIMS, yet remains a challenging geography for the lab informatics providers owing to data
storage regulations, language barriers and rising need for customization.
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
LIMS SDMS
CDS ELN
EDC & CDMS ECM
LES
14. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 14
China Laboratory Informatics Market Revenue Share, By Product Types
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025
CAGR
2015-19
CAGR
2020-25
ELN 2.13 XX XX XX XX XX XX XX XX XX XX XX XX
LIMS 29.91 XX XX XX XX XX XX XX XX XX XX XX XX
CDS 8.29 XX XX XX XX XX XX XX XX XX XX XX XX
EDC &CDMS 2.82 XX XX XX XX XX XX XX XX XX XX XX XX
LES 1.38 XX XX XX XX XX XX XX XX XX XX XX XX
ECM 3.17 XX XX XX XX XX XX XX XX XX XX XX XX
SDMS 7.74 XX XX XX XX XX XX XX XX XX XX XX XX
Table 1: China Laboratory Informatics Market, By Types, By Revenues (USD Million), 2019 - 2025F
Source: MarkNtel Advisors
• Scientific Data Management Systems (SDMS): The deployment of Scientific Data management Systems in China has been witnessing an
uptick on account of rising demand for automatic file processing, automation of the approval methodology of key SOPs, creating a
customized workflow in addition to ensuring regulatory compliances. Pharmaceutical firms were the key end-users of SDMS in 2019 and
it is expected that pharma companies would continue to be the hotspot for such solutions in the forthcoming years.
• Chromatography Data Management Systems (CDS): CDS systems in China are witnessing an uptrend as the end-users are progressively
integrating chromatography equipment. The demand for a networked system that controls multiple instruments in one or more labs.
Evolving medical device compliances are further catalyzing the sales of CDS in China.
15. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 15
XX%
XX%
XX%
XX%
China Laboratory Informatics Market Revenue Share, By Component
Figure 5: China Laboratory Informatics Market Revenue Share, By Component, 2019 & 2025F (Percentage)
Source: MarkNtel Advisors
2025F
2019
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025
CAGR
2015-19
CAGR
2020-25
Services 13.47 XX XX XX XX XX XX XX XX XX XX XX XX
Software 41.96 XX XX XX XX XX XX XX XX XX XX XX XX
Table 2: China Laboratory Informatics Market, By Component, By Revenues (USD Million), 2019 & 2025F
Source: MarkNtel Advisors
Services Software
16. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 16
China Laboratory Informatics Market Revenue Share, By Deployment Model
Figure 6: China Laboratory Informatics Market Revenue Share, By Deployment Model, 2019 - 2025F
Source: MarkNtel Advisors
64.40% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
35.60% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
On-Premise Cloud Based
*These are dummy charts and do not represent actual value
Source: MarkNtel Advisors
2015F 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR
2015-19
CAGR
2020-25
On-Premise 35.70 XX XX XX XX XX XX XX XX XX XX XX XX
Cloud 19.74 XX XX XX XX XX XX XX XX XX XX XX XX
Table 3: China Laboratory Informatics Market, By Deployment Model, By Revenues (USD Million), 2019 & 2025F
17. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 17
China Laboratory Informatics Market Revenue Share, By End User
Figure 7: China Laboratory Informatics Market Revenue Share, By End User, 2019 & 2025F
Others: Petrochemicals, Food Testing
Source: MarkNtel Advisors
2019:
USD XX Million
Pharmaceutical
and
Biotechnology
CRO
Chemicals
Environment
Testing Labs
Others
2019 2025
XX% XX%
2019 2025
XX% XX%
2019 2025
XX% XX%
2019 2025
XX% XX%
2019 2025
XX% XX%
• Most Potential
Areas
• 88% of CRO in
China are into
healthcare, life
sciences and
pharmaceuticals
18. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 18
China Laboratory Informatics Market Revenue Share, By End Users
Figure 8: China Laboratory Informatics in Pharmaceuticals & Bio-Technology Market Revenues (USD Million), 2015- 2025F
XX XX XX XX XX XX XX XX XX
XX
XX
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR: XX%
CAGR: XX%
Source: MarkNtel Advisors
• China is the amongst few of the largest healthcare market in the world due to the massive demography, aging population, frequent
epidemics, etc. The country is also a pharmaceutical and biotech powerhouse with an annual output above USDXX bn in 2019, which is
projected to exceed USDXX bn by 2022. Favorable government policies, lower research and development cost, and technological
innovations have the key drivers for the pharma and biotech market in China.
• With the integration of technology towards cost-cutting and driving innovation, the laboratory informatics installation is soaring in the
pharmaceuticals and biotechnology centers of China. Apart from using LIMS, and SDMS, the adoption of ELN is on the rise as the
companies are progressively looking to use the information from diverse sources and IPR to be combined with in house findings on the
ELN, implying chemical compounds, related physical and pharmacological properties, and synthesize information to be integrated at the
appropriate point in the workflow. The usage of LIMS is also getting traction among the Chinese pharma manufacturers for resource
management, forecast fewer sample volume and resource needs, identify process failures, etc.
19. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 19
China Laboratory Informatics Market Revenue Share, By End Users
• Biobanking and biorepositories have been registering an explosive growth in China, with a chain of biobanks and repositories seeing the
daylight during 2010-19. In 2019, the country established the world’s largest and most modern biobank China National GeneBank
(CNGB), approved and funded by the Chinese government to a cost of over USD1 billion.
• During 2010-19, several biobanks across the country have emerged while numerous have strengthened their operations including China
Kadoorie Biobank, Shanghai Zhangjiang Biobank, etc. Besides, several hospitals, specialty care centers have been establishing biobanks to
explore the growing market potential. The growing deployment of laboratory informatics in biobanks in China has been attributed to its
ability to manage the entire lifecycle of samples and their data.
• The healthcare and life sciences institutes in the country are increasingly exploring the Lab Informatics software meeting the regulatory
guidelines with the purpose of traceability of biospecimens from reception to shipment, genealogy of samples, interoperability with the
capabilities to integrate with EMR/ EHR records, etc.
Source: MarkNtel Advisors
Figure 9: China Laboratory Informatics in Contract Research Organizations (CRO) Market Revenues (USD Million), 2015- 2025F
9.67 XX XX XX XX XX XX XX
XX
XX
XX
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR: XX%
CAGR: XX%
20. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 20
China Laboratory Informatics Market Revenue Share, By End Users
Figure 10: China Laboratory Informatics in Chemicals Market Revenues (USD Million), 2015- 2025F
14.36 XX XX XX XX XX XX
XX
XX
XX
XX
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR: XX%
CAGR: XX%
Source: MarkNtel Advisors
• China is the chemical manufacturing hub of the world. The country amassed around 40% of the global chemical industry revenues in
2019. China’s chemical-R&D spending is now among the world’s leaders. The structure of China’s chemical-industry R&D has also
changed, moving from one in which initiatives were under government direction to one primarily driven by individual companies within
an ecosystem of collaboration with government research institutions and universities—and that has a strengthened regime to protect
intellectual property. Therefore, the investments in research and development labs in the chemical industry of China are soaring.
• The Chinese companies investing into research & development on green chemicals, specialty chemicals, etc. have been stimulating the
adoption of lab informatics solutions. The manufacturers are increasingly deploying digital technologies to integrate cross functional
collaboration among R&D, manufacturing, and sales functions, forecasting the future trends based on quantitative information.
21. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 21
China Laboratory Informatics Market Revenue Share, By End Users
Figure 11: China Laboratory Informatics in Pharmaceuticals & Bio-Technology Market Revenues (USD Million), 2015- 2025F
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
Environment Testing Labs Others
CAGR: XX%
CAGR: XX%
CAGR: XX%
CAGR: XX%
Source: MarkNtel Advisors
• The country has been witnessing an influx of space and earth observation labs, soil testing labs, R&D in air quality monitoring, aerospace
& defense, etc. Such labs are generating the fresh stimulus to the industry growth. The modernization of legacy IT infrastructure in the
government research labs primarily in aerospace and defense, heavy machinery, etc., is exhibiting an uptick. These labs are more inclined
towards deployment of LIMS and CDS. The traction towards ELN and LES remains feeble.
• The other form of labs such as food testing, petrochemicals, etc., are slow in modernizing their exiting infrastructure in comparison to labs
in other segments due to lower annual budget.
22. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 22
China Laboratory Informatics Market Revenue Share, By Company
Sr. No
Name of the
Company
Revenue
Share
1 Thermofisher Scientific XX
2 Perkin Elmer XX
3 Abbott Informatics XX
4 Agilent XX
5 Labware XX
6 LabVantage XX
7 Autoscribe XX
8 Waters XX
9 Others* XX
Table 4: China Laboratory Informatics Revenue Share, By Company, 2019
Others include: Lablinks, NuJenesis, Siemens SA, Illumina, BT Lims etc.
Source: MarkNtel Advisors
23. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.
China Laboratory Informatics Market Key
Strategic Imperatives for Growth & Success
9
24. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 24
Key Strategic Imperatives for Success
Tapping the Rising Potential for Electronic Lab Notebooks
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Need of Laboratory Informatics for Precision Medicine
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX.
One Integrated Solution for Laboratories
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
25. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 25
Disclaimer
MarkNtel Advisors provides market specific information
that is intended for key sets of customers which can be
used for internal purposes, but not for general publication
or disclosure to third parties.
No part of the report can be, lent, resold or disclosed to
non-customers without written permission. No part may
be reproduced, stored in a retrieval system or transmitted
in any form or by any means, electronic, mechanical,
photocopying, recording or otherwise, without the
permission of the publisher. The Market specific
information is based on primary interviews and MarkNtel
Advisors takes no responsibility for any incorrect
information provided to us. MarkNtel Advisors would not
be held responsible for any loss or damage caused due to
the usage of such information and thus would not refund in
any case the amount spent by the company in purchasing
such information.
+1 (613) 707-5086
sales@marknteladvisors.com